~~<i id='F2B299ABF7'><strike id='F2B299ABF7'><tt id='F2B299ABF7'><pre id='F2B299ABF7'></pre></tt></strike></i>~~

Home» Wikipedia» hotspot

hotspot

author：knowledge 2025-09-29 06:48:48 Page View：361

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： SAMSHA loosens regulations on methadone treatment centers
Next article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

knowledge

Continuity nursing helped my family in our darkest PICU moments

EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

ARCH Venture Partners is raising $3 billion for a life sciences fund

AdobeARCHVenturePartners,oneofthetopinvestorsinthebiotechecosystem,israising$3billionforanewfund.The

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

Asbestos ban is immediate, but health effects will linger for decades

BrookMitchell/GettyImagesAnewruleannouncedbytheEnvironmentalProtectionAgencythisweekputsanendtotheus

WSS

hotspot

hotspot

explore

knowledge

Asbestos ban is immediate, but health effects will linger for decades